Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSL
501
Brightstar Lottery PLC
BRSL
$2.21B
| $2.55M | 0.05% |
112,345
+25,314
| +29% | +$549K |
|
502
Robert Half
RHI
$4.58B
| $2.54M | 0.05% |
+34,459
| New | +$2.63M |
|
503
PUT
Dick's Sporting Goods
DKS
$16.4B
| $2.54M | 0.05% |
+21,100
| New | +$2.38M |
|
504
Gulfport Energy Corp
GPOR
$3.07B
| $2.54M | 0.05% |
34,471
+604
| +2% | +$50K |
|
505
Treace Medical Concepts
TMCI
$282M
| $2.54M | 0.05% |
110,393
+38,357
| +53% | +$883K |
|
506
Boot Barn
BOOT
$5.01B
| $2.53M | 0.05% |
40,526
-6,947
| -15% | -$417K |
|
507
CALL
O'Reilly Automotive
ORLY
$72.1B
| $2.53M | 0.05% |
+45,000
| New | +$2.42M |
|
508
Dine Brands
DIN
$454M
| $2.52M | 0.05% |
39,038
+1,374
| +4% | +$95.7K |
|
|
MDC
509
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.52M | 0.05% |
79,802
-35,622
| -31% | -$1.1M |
|
|
BDN
510
Brandywine Realty Trust
BDN
$522M
| $2.52M | 0.05% |
409,085
+182,609
| +81% | +$1.17M |
|
|
HES
511
CALL
DELISTED
Hess
HES
| $2.51M | 0.05% |
17,700
+11,200
| +172% | +$1.54M |
|
512
3D Systems Corp
DDD
$530M
| $2.5M | 0.05% |
337,922
+65,360
| +24% | +$573K |
|
513
AZZ Inc
AZZ
$4.25B
| $2.5M | 0.05% |
62,117
+45,630
| +277% | +$1.79M |
|
514
CALL
Microchip Technology
MCHP
$41.3B
| $2.49M | 0.05% |
35,500
-2,800
| -7% | -$193K |
|
515
iShares US Medical Devices ETF
IHI
$3.49B
| $2.49M | 0.05% |
47,315
+34,011
| +256% | +$1.73M |
|
516
Thor Industries
THO
$4.14B
| $2.48M | 0.05% |
32,885
-60,984
| -65% | -$4.9M |
|
517
PUT
Crown Castle
CCI
$32.1B
| $2.48M | 0.05% |
+18,300
| New | +$2.47M |
|
518
PUT
Lam Research
LRCX
$393B
| $2.48M | 0.05% |
59,000
+49,000
| +490% | +$2.05M |
|
519
State Street Materials Select Sector SPDR ETF
XLB
$8.87B
| $2.48M | 0.05% |
+63,782
| New | +$2.45M |
|
520
CALL
Intuitive Surgical
ISRG
$134B
| $2.47M | 0.05% |
9,300
+5,100
| +121% | +$1.24M |
|
521
iShares MSCI Japan ETF
EWJ
$22.4B
| $2.46M | 0.05% |
+45,277
| New | +$2.38M |
|
|
CMRC
522
Commerce.com Inc Series 1
CMRC
$184M
| $2.46M | 0.05% |
281,422
+161,098
| +134% | +$1.75M |
|
523
La-Z-Boy
LZB
$1.35B
| $2.46M | 0.05% |
107,769
+56,165
| +109% | +$1.37M |
|
524
Asana
ASAN
$2.21B
| $2.45M | 0.05% |
178,196
+154,422
| +650% | +$2.8M |
|
525
Madrigal Pharmaceuticals
MDGL
$11.9B
| $2.45M | 0.05% |
8,445
+617
| +8% | +$60.3K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.